Loading...
Diclofenac sodium (Voltaren) is a nonsteroidal antiinflammatory drug recently released for use in the United States. Mild, asymptomatic elevation of serum aminotransferase levels are common with this drug, but this case series indicates that severe and even fatal hepatic dysfunction may occur.
The investigators describe seven patients in whom signs and symptoms of hepatotoxicity developed within several weeks to several months of initiating diclofenac, which generally resolved 4 to 6 weeks after it was discontinued. One patient, a 65-year-old woman who was being treated for osteoarthritis, developed fulminant hepatitis and died despite discontinuation of the drug. The only patient to be "rechallenged" with diclofenac had a recurrence of righ…